Literature DB >> 16034685

A new job: research volunteer?

Giovan Maria Zanini1, Claudio Marone.   

Abstract

We report three years of experience with a newly introduced register for healthy research volunteers in Canton Ticino, Southern Switzerland. The aim of the register was to encourage responsible participation in medical research, and to detect fraud due to volunteers taking part in more than one study at the same time. All healthy volunteers participating in drug studies approved by the Research Ethics Committee were included in the register and given a special code. During three years, in a population of 1436 volunteers involved in 152 studies, 192 subjects (13.4%) were identified as habitual or regular volunteers (they participated regularly, limiting the pause between studies to the minimum of three months as required by the regulations of the Research Ethics Committee). Among them, only three subjects gave false information and were identified. Most volunteers participated in studies only sporadically (54% in one, 21% in two over three years) and 82.4% of the volunteers were involved, on average, in only one study per year. Our register permits fraud detection as well as analysis of the research population from an epidemiological point of view. It has been well accepted from both volunteers and research organisations. It is simple and represents a substantial contribution especially for organisations, which need to recruit a large number of subjects for their research.

Mesh:

Year:  2005        PMID: 16034685     DOI: 2005/21/smw-10956

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  3 in total

1.  Healthy volunteer registries and ethical research principles.

Authors:  E A Kupetsky-Rincon; W K Kraft
Journal:  Clin Pharmacol Ther       Date:  2012-06       Impact factor: 6.875

2.  A national registry for healthy volunteers in phase 1 clinical trials.

Authors:  David B Resnik; Greg Koski
Journal:  JAMA       Date:  2011-03-15       Impact factor: 56.272

3.  Mitigating the Effects of Nonadherence in Clinical Trials.

Authors:  Thomas M Shiovitz; Earle E Bain; David J McCann; Phil Skolnick; Thomas Laughren; Adam Hanina; Daniel Burch
Journal:  J Clin Pharmacol       Date:  2016-01-22       Impact factor: 3.126

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.